CompletedNot Applicable

EFFECT OF BLOOD PRESSURE MEASUREMENT IN DIFFERENT POSITIONS ON BLOOD PRESSURE VALUES AND ANXIETY LEVELS IN PREGNANT WOMEN WITH PREECLAMPSIA

Turkey (Türkiye)96 participantsStarted 2024-03-01

Plain-language summary

Aim: This study examined the effects of blood pressure measurement in different positions on diastolic and systolic blood pressure values and anxiety levels in pregnant women diagnosed with preeclampsia. Method: The study was conducted between March and June 2024 as a pre-test post-test quasi-experimental study with 96 pregnant women diagnosed with preeclampsia in the perinatology department of a training and research hospital. Participants were divided into three groups and their blood pressures were measured in the left lateral, right lateral and semi-Fowler positions. Data were collected using an introductory information form and the State Anxiety Scale.

Who can participate

Age range

18 Months – 45 Months

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Being primigravida (first pregnancy), * Being in the third trimester of pregnancy, * Being between the ages of 18-45, * Being diagnosed with preeclampsia, * Having an arm circumference of less than 36 cm, * Having a history of hospitalization of at least 24 hours (in order to minimize anxiety, uncertainty, lack of information and disorientation related to hospitalization). Exclusion Criteria: * • Presence of a physical disability that would make it difficult to perform the positions included in the study (e.g. loss of extremity), * Presence of decompensated disease (e.g. eclampsia, pulmonary edema), * Presence of a history of cardiological disease, * Diagnosis of obstructive sleep apnea, * Presence of additional risk factors other than preeclampsia (e.g. threat of premature birth, placental anomalies).

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

blood pressure measurement

Timeframe: 4 month

anxiety levels

Timeframe: 4 month

Trial details

NCT IDNCT06898567

SponsorIstanbul University - Cerrahpasa

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-06-01

View on ClinicalTrials.gov More Preeclampsia trials